Search Results - "Dilber, M S"

Refine Results
  1. 1

    Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22 by DILBER, M. S, PHELAN, A, AINTS, A, MOHAMED, A. J, ELLIOTT, G, SMITH, C. I. E, O'HARE, P

    Published in Gene therapy (1999)
    “…We demonstrate that fusion proteins consisting of the herpes simplex virus (HSV) transport protein VP22 linked in frame to HSV thymidine kinase (tk) retain the…”
    Get full text
    Journal Article
  2. 2

    OuaSelect, a novel ouabain-resistant human marker gene that allows efficient cell selection within 48 h by TRESCHOW, A, UNGER, C, AINTS, A, FELLDIN, U, ASCHAN, J, DILBER, M. S

    Published in Gene therapy (01-11-2007)
    “…Efficient selection of gene-modified cells is required for a number of potential gene therapy applications, as well as molecular biology studies. Ideally, a…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Evaluation of ex vivo expanded human NK cells on antileukemia activity in SCID-beige mice by GUIMARAES, F, GUVEN, H, DONATI, D, CHRISTENSSON, B, LJUNGGREN, H. G, BEJARANO, M. T, DILBER, M. S

    Published in Leukemia (01-05-2006)
    “…The possibility of using natural killer (NK) cells in treatment of human hematological malignancies has increased in recent years. One factor contributing to…”
    Get full text
    Journal Article
  5. 5

    Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy by Guven, H, Gilljam, M, Chambers, B J, Ljunggren, H G, Christensson, B, Kimby, E, Dilber, M S

    Published in Leukemia (01-10-2003)
    “…B-cell chronic lymphocytic leukemia (B-CLL) is the most common leukemia in the Western world. It is currently an incurable disease, making new treatment…”
    Get full text
    Journal Article
  6. 6

    Suicide gene therapy: possible applications in haematopoietic disorders by Dilber, M. S., Gahrton, G.

    Published in Journal of internal medicine (01-04-2001)
    “… Dilber MS, Gahrton G (Huddinge University Hospital, Karolinska Institutet, Huddinge, Sweden). Suicide gene therapy: possible applications in haematopoietic…”
    Get full text
    Journal Article Conference Proceeding
  7. 7

    Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia by CARLENS, S, ASCHAN, J, REMBERGER, M, DILBER, M. S, RINGDEN, O

    Published in Bone marrow transplantation (Basingstoke) (01-09-1999)
    “…Low-dose cyclosporine (CsA), starting at 1 mg/kg/day i.v. with early discontinuation, and four doses of methotrexate (MTX), was given to 82 consecutive…”
    Get full text
    Journal Article
  8. 8

    Gap junctions promote the bystander effect of herpes simplex virus thymidine kinase in vivo by DILBER, M. S, ABEDI, M. R, CHRISTENSSON, B, BJÖRKSTRAND, B, KIDDER, G. M, NAUS, C. C. G, GAHRTON, G, SMITH, C. I. E

    Published in Cancer research (Chicago, Ill.) (15-04-1997)
    “…Transfer of the herpes simplex thymidine kinase gene (HSVtk) into tumor cells followed by the administration of ganciclovir (GCV) provides a potential strategy…”
    Get full text
    Journal Article
  9. 9

    Long-term follow-up of gene-marked CD34 cells after autologous stem cell transplantation for multiple myeloma by Alici, E, Björkstrand, B, Treschow, A, Aints, A, Smith, C I E, Gahrton, G, Dilber, M S

    Published in Cancer gene therapy (01-03-2007)
    “…Gene marking can be used to investigate if progenitor cells harvested from patients are contaminated with tumorigenic cells. It can also provide information…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Mapping of herpes simplex virus-1 VP22 functional domains for inter- and subcellular protein targeting by Aints, A, Güven, H, Gahrton, G, Smith, C I, Dilber, M S

    Published in Gene therapy (01-07-2001)
    “…The herpes simplex virus 1 (HSV-1) tegument protein VP22 has been utilised as a vehicle for trafficking proteins. It has a remarkable property of exiting the…”
    Get full text
    Journal Article
  12. 12

    Suicide Gene Therapy for Plasma Cell Tumors by Dilber, M.Siraç, Abedi, Mohammad R., Björkstrand, Bo, Christensson, Birger, Gahrton, Gösta, Xanthopoulos, Kleanthis G., Smith, C.I.Edvard

    Published in Blood (15-09-1996)
    “…Suicide gene therapy for plasma cell tumors was attempted in severe combined immunodeficient (SCID) mice injected with human myeloma cell lines. Initially, a…”
    Get full text
    Journal Article
  13. 13

    Genetically Modified Autoactivated Cells Expressing Intracellular Forms of GM‐CSF as a Model for Regulated Administration of Cytokines by Arteaga, H. J., Mohamed, A. J., Christensson, B., Mahdy, E., Gahrton, G., Smith, C. I. E., Dilber, M. S.

    Published in Scandinavian journal of immunology (01-11-2005)
    “…The application of cytokines for immunotherapy is frequently hampered by undesirable side effects. To avoid systemic effects, cytokines can be directly…”
    Get full text
    Journal Article
  14. 14

    Unrelated donor stem cell transplantation after autologous transplantation : experience of a single center by ASCHAN, J, REMBERGER, M, CARLENS, S, MATTSSON, J, DILBER, M, LÖNNQVIST, B, BJÖRKSTRAND, B

    Published in Bone marrow transplantation (Basingstoke) (01-08-1999)
    “…Patients who do not respond to autologous stem cell transplantation (ASCT) have a poor prognosis. Concerns about toxicity limit the use of unrelated donor stem…”
    Get full text
    Journal Article
  15. 15

    Suicide genes and bystander killing: local and distant effects by Dilber, M S, Smith, C I

    Published in Gene therapy (01-04-1997)
    “…The mechanism underlying suicide gene therapy is not fully resolved but seems to be complex. Results from two recent studies now demonstrate that the level of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    A new method for in vitro expansion of cytotoxic human CD3 −CD56 + natural killer cells by Carlens, Stefan, Gilljam, Mari, Chambers, Benedict J, Aschan, Johan, Guven, Hayrettin, Ljunggren, Hans-Gustaf, Christensson, Birger, Dilber, M.Sirac

    Published in Human immunology (01-10-2001)
    “…Adoptive transfer of immunocompetent cells may induce anti-tumor effects in vivo. However, a significant obstacle to the development of successful cellular…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Retroviral-mediated gene transfer into human bone marrow stromal cells: studies of efficiency and in vivo survival in SCID mice by Li, K J, Dilber, M S, Abedi, M R, Björkstrand, B, Smith, C I, Garoff, H, Gahrton, G, Xanthopoulos, K G

    Published in European journal of haematology (01-11-1995)
    “…Retroviral-mediated gene transfer into bone marrow cells is extensively used in gene therapy protocols. Cytokines are needed for stimulation, to achieve a high…”
    Get more information
    Journal Article
  20. 20